1,1,1-trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-Methanesulfonamide

Englisch Name:: 1,1,1-trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-Methanesulfonamide

Synonyma:: 1,1,1-trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d;1,1,1-Trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-methanesulfonamide;1,1,1-trifluoro-N-(4-oxido-2,6-diphenyl-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide;1,1,1-Trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide;(11bR)-1,1,1-Trifluoro-N-(4-oxido-2,6-diphenyl-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide;1,1,1-trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-Methanesulfonamide;1,?1,?1-?Trifluoro-?N-?[(11bR)?-?8,?9,?10,?11,?12,?13,?14,?15-?octahydro-?4-?oxido-?2,?6-?diphenyl-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphe;Methanesulfonamide, 1,1,1-trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 19

1,1,1-trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-Methanesulfonamide Eigenschaften

Sicherheit

Bildanzeige (GHS)

Alarmwort

Warnung

Gefahrenhinweise

Code	Gefahrenhinweise	Gefahrenklasse	Abteilung	Alarmwort	P-Code
H302	Gesundheitssch?dlich bei Verschlucken.	Akute Toxizit?t oral	Kategorie 4	Warnung	P264, P270, P301+P312, P330, P501
H315	Verursacht Hautreizungen.	Hautreizung	Kategorie 2	Warnung	P264, P280, P302+P352, P321,P332+P313, P362
H319	Verursacht schwere Augenreizung.	Schwere Augenreizung	Kategorie 2	Warnung	P264, P280, P305+P351+P338,P337+P313P
H335	Kann die Atemwege reizen.	Spezifische Zielorgan-Toxizit?t (einmalige Exposition)	Kategorie 3 (Atemwegsreizung)	Warnung

Sicherheit

P280	Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P305+P351+P338	BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen.

Global( 19)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shanghai Daken Advanced Materials Co.,Ltd	+86-2158073036	info@dakenam.com	China	14014	58
Career Henan Chemica Co	+86-0371-86658258 +8613203830695	laboratory@coreychem.com	China	30224	58
Daicel Chiral Technologies (China)CO.,LTD	021-50460086-9 15921403865	han_yajun@dctc.daicel.com	China	7676	65
Tianjin Derchemist Science & Technology Co., Ltd.	22-58627059 13920586291	zdcomcon@126.com	China	4095	50
Shanghai Chiral bio-compound co., Ltd.	021-5068 3667/17749785980/1029026415; 17749785980	1029026415@qq.com	China	4359	58
LaaJoo	021-60702684 18516024827	huang.jiayi@sinocompound.com	China	2280	58
Greenherbs Science and Technology Development Co., Ltd.	010-61136123	pub02@greenherbs.com.cn	China	4049	58
Shanghai Anyinuo Biomedical Technology Co., Ltd.	021-34625901 18018851262;	420970979@qq.com	China	5960	58
Shanghai Suifu Chemical Technology CO.,LTD.	33738187 19945655289	suifuchemical@163.com	China	500	58
Henan Weituxi Chemical Technology Co., Ltd.	0371-63284658 18135795563	3905209149@qq.com	China	9809	58

1,1,1-trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-Methanesulfonamide
1,1,1-trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d
Methanesulfonamide, 1,1,1-trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-
(11bR)-1,1,1-Trifluoro-N-(4-oxido-2,6-diphenyl-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide
1,?1,?1-?Trifluoro-?N-?[(11bR)?-?8,?9,?10,?11,?12,?13,?14,?15-?octahydro-?4-?oxido-?2,?6-?diphenyl-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphe
1,1,1-Trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide
1,1,1-Trifluoro-N-[(11bR)-8,9,10,11,12,13,14,15-octahydro-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-methanesulfonamide
1,1,1-trifluoro-N-(4-oxido-2,6-diphenyl-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide
1261302-62-8
C33H29F3NO5PS